AMY YOUNG: Open Payments
NPI 1891410395 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 73 payments from 24 companies in 2025. Trend: 2023 $395 · 2024 $414 · 2025 $1,713
Food & beverage: $1,618Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $274 |
| AstraZeneca Pharmaceuticals LP | 8 | $177 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| Incyte Corporation | 5 | $112 |
| Eisai Inc. | 4 | $98 |
| Astellas Pharma US Inc | 1 | $95 |
| Daiichi Sankyo Inc. | 4 | $94 |
| Tempus AI, Inc | 4 | $78 |
| Pharmacosmos Therapeutics Inc. | 3 | $73 |
| Genmab U.S., Inc. | 3 | $69 |
Products named: ERLEADA, PLUVICTO, Lenvima, MONJUVI, Enhertu, IMFINZI, XT CDX, MONOFERRIC.
Industry payments across PA — which companies pay providers there.
